Swedbank AB Makes New $2.27 Million Investment in Amrize Ltd $AMRZ

Swedbank AB purchased a new position in shares of Amrize Ltd (NYSE:AMRZ) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 41,971 shares of the company’s stock, valued at approximately $2,270,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Laurel Wealth Advisors LLC bought a new position in shares of Amrize during the 4th quarter worth about $34,000. State of Wyoming bought a new position in shares of Amrize during the 3rd quarter worth about $32,000. US Bancorp DE bought a new position in shares of Amrize during the 3rd quarter worth about $38,000. Costello Asset Management INC bought a new position in shares of Amrize during the 3rd quarter worth about $44,000. Finally, LRI Investments LLC bought a new position in shares of Amrize during the 4th quarter worth about $57,000.

Insiders Place Their Bets

In other Amrize news, CEO Jan Philipp Jenisch purchased 60,000 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The shares were acquired at an average price of $58.05 per share, with a total value of $3,483,000.00. Following the transaction, the chief executive officer owned 1,703,582 shares in the company, valued at $98,892,935.10. The trade was a 3.65% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CTO Roald Brouwer purchased 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 11th. The stock was acquired at an average cost of $58.72 per share, for a total transaction of $176,160.00. Following the transaction, the chief technology officer owned 16,257 shares in the company, valued at $954,611.04. This represents a 22.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 131,554 shares of company stock worth $7,152,069 in the last 90 days. Company insiders own 0.54% of the company’s stock.

Amrize Price Performance

Shares of NYSE AMRZ opened at $53.13 on Thursday. Amrize Ltd has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The stock has a market cap of $29.39 billion and a price-to-earnings ratio of 25.42. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. The firm’s 50-day simple moving average is $54.51 and its 200 day simple moving average is $55.13.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The business had revenue of $2.18 billion during the quarter. The company’s revenue was up 4.7% on a year-over-year basis. As a group, research analysts anticipate that Amrize Ltd will post 2.76 earnings per share for the current fiscal year.

Amrize Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were given a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is presently 21.05%.

Analysts Set New Price Targets

A number of research firms have recently issued reports on AMRZ. JPMorgan Chase & Co. increased their price objective on shares of Amrize from $60.00 to $70.00 and gave the stock an “overweight” rating in a research report on Thursday, March 5th. Oppenheimer set a $68.00 price objective on shares of Amrize in a research report on Friday, May 1st. Vertical Research raised shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a research report on Friday, May 1st. Wells Fargo & Company cut their price objective on shares of Amrize from $66.00 to $65.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 15th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a research report on Monday, February 23rd. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $64.86.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.